Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc

Sector: Healthcare   

Industry: Biotechnology

131.75
 
USD
  
-0.98
  
(-0.74%)
Optionable: Yes  Market Cap: 8,324 M  90-day average vol: 492,533

Previous close: 132.73  Open: 132.7  Bid: 129.61  Ask: 134.03
52 week range    
120.64   
   160.96
Peers   
ENDP / 
ABC / 
TEVA / 
Last updated: Sunday 24th September 2023
32
MarketXLS Rank
40
Value
7
Technical
50
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ABC

0.013529 B18.4139.41

ENDP

1 B11.43.14

NVS

TEVA

Financials

JAZZ Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AcquiredInProcessRnDIncome-638000.0
Amortization-79 M127 M98 M102 M152 M201 M355 M260 M526 M599 M
Amortization of intangibles-79 M127 M98 M102 M152 M201 M355 M260 M526 M599 M
Basic EPS from continuing operations3.710.98
Basic EPS total3.710.985.386.568.137.459.224.28-5.52-3.58
Basic weighted shares outstanding58 M60 M61 M61 M60 M60 M57 M56 M60 M63 M
Cost of sales122 M128 M149 M441 M541 M
Depreciation-12 M-13 M-15 M-15 M-19 M-27 M-30 M
Depreciation unreconciled127 M98 M102 M152 M201 M355 M260 M526 M599 M
DepreciationAndAmortization127 M98 M102 M152 M201 M355 M260 M526 M599 M
DevelopmentExpense5 M203 M24 M85 M110 M251 M444 M
Diluted EPS total3.510.935.236.417.967.39.094.22-5.52-3.58
Diluted normalized net income/share3.510.93
Diluted weighted shares outstanding62 M63 M63 M62 M61 M61 M58 M57 M60 M63 M
Earnings from equity interest-379000.0-1 M-4 M-4 M-3 M-714000.0-10 M
EarningsFromEquityInterestNetOfTax-379000.0-1 M-4 M-4 M-3 M-714000.0-10 M
Fees1000000.0
GainOnSaleOfBusiness-638000.0100000.0-1 M
GainOnSaleOfPPE-473000.0-655000.0-21000.0
GainOnSaleOfSecurity-17 M
GeneralAndAdministrativeExpense-9 M-11 M-10 M-12 M-15 M-12 M-25 M-26 M-30 M-26 M
Gross operating profit872 M1,173 M1,325 M1,488 M1,619 M1,769 M2,034 M2,215 M2,653 M3,119 M
ImpairmentOfCapitalAssets39 M32 M43 M136 M134 M
Income before tax308 M152 M436 M532 M441 M529 M454 M275 M-113 M-373 M
Income restructuring and M&A-2 M-2 M
Income taxes92 M94 M106 M135 M-48 M80 M-73 M34 M216 M-159 M
Interest income-27 M-53 M-57 M-62 M-78 M-77 M-72 M-100 M-279 M-288 M
InterestExpenseNonOperating-27 M-38 M-57 M-59 M-88 M-90 M-33 M
InterestIncomeOperating-4 M
MinorityInterests1 M1000.0
MiscOtherSpecialCharges-2 M9 M1 M7 M5 M5 M3 M2 M
Net income from total operations216 M58 M330 M397 M488 M447 M523 M239 M-330 M-224 M
NetIncomeCommonStockholders216 M58 M330 M397 M488 M447 M523 M239 M-330 M-224 M
NetIncomeContinuousOperations216 M58 M330 M397 M488 M447 M523 M239 M-330 M-224 M
NetNonOperatingInterestIncomeExpense-27 M-53 M-57 M-62 M-78 M-77 M-72 M-100 M-279 M-288 M
Operating income340 M235 M540 M592 M529 M658 M532 M514 M170 M68 M
Operating income before depreciation (EBITDA)390 M299 M567 M641 M598 M733 M812 M466 M350 M224 M
OperatingExpense-532 M-977 M-817 M-896 M-1,090 M1,112 M1,501 M1,700 M2,483 M3,051 M
Other income net2 M-9 M17 M1 M1 M4 M4 M3 M714000.010 M
OtherGandA-9 M-11 M-10 M-12 M-15 M-12 M-25 M-26 M-30 M-26 M
OtherOperatingExpenses181 M117 M103 M105 M110 M-23 M-28 M-28 M-27 M-25 M
PromotionAndAdvertising-1000000.0-1000000.0-28 M-29 M-37 M-37 M-65 M-100 M-161 M-109 M
RealizedCapitalGain-4 M
RentAndLandingFees-9 M-11 M-10 M-12 M-15 M-12 M
Research & development expense47 M288 M135 M186 M283 M227 M410 M587 M506 M1,035 M
ResearchExpense42 M85 M135 M162 M198 M227 M300 M335 M506 M590 M
RestructringAndMnAIncome-2 M-2 M
SalariesAndWages-45 M-70 M-92 M-99 M-107 M-102 M-111 M-121 M-189 M-222 M
Selling Gen & administrative expense304 M406 M449 M503 M544 M684 M737 M854 M1,452 M1,417 M
SellingAndMarketingExpense304 M406 M449 M503 M544 M684 M737 M854 M1,452 M1,417 M
SellingExpense304 M406 M449 M503 M544 M684 M737 M854 M1,452 M1,417 M
Special income/charges-39 M-32 M-43 M-136 M-134 M
Total Income available for interest expense (EBIT)308 M152 M436 M505 M403 M473 M395 M187 M-203 M-406 M
Total common shares outstanding58 M61 M61 M60 M60 M57 M56 M56 M62 M63 M
Total net income216 M58 M330 M397 M488 M447 M523 M239 M-330 M-224 M
Total ordinary shares63 M63 M63 M63 M63 M63 M63 M63 M63 M63 M
Total revenues872 M1,173 M1,325 M1,488 M1,619 M1,891 M2,162 M2,364 M3,094 M3,659 M
TotalExpenses-532 M-977 M-817 M-896 M-1,090 M1,233 M1,629 M1,849 M2,924 M3,591 M
TotalRevenue865 M1,163 M1,317 M1,477 M1,619 M1,891 M2,162 M2,364 M3,094 M3,659 M
WriteDown-13 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and Templates.
Get started today